Microbicides Testing - EpiVaginal™Infection through the vaginal-ectocervical (VEC) tissue is believed to be the main route for the heterosexual transmission of the human immunodeficiency virus (HIV) in women.
Recently, a tissue culture-based model of the VEC (EpiVaginal) has been developed. Normal, human VEC epithelial and dendritic cell co-cultures were used to form a three-dimensional tissue using specially formulated medium. The in vitro engineered tissue reproduces many of the histological and ultrastructural features including basal, parabasal, glycogenated intermediate, and the superficial cell layers.
Preliminary experiments showed the use of this tissue model and the MTT tissue viability assay for predicting VEC irritation of microbicides*. Different concentrations of Nonoxynol-9 (N-9), carrageenin-I, and methyl cellulose were dosed topically and the viability of the VEC tissue was determine by MTT.
Following 24 hr exposure to N-9 (0.1%) tissue viability was reduced to 51%. In contrast, carrageenin-I (20%) reduces viability to 77% and no effect was observed for methyl cellulose (up to 20%). H & E staining showed irritation of epithelial lining following N-9 treatment greater than or equal to 0.1%. Experiments also showed that HIV virions do not pass freely through the tissue but they infect cells in the reconstructed VEC tissue model containing dendritic cells.
In conclusion, the tissue model is likely to serve as a useful tool to screen new or existing microbicide formulations for vaginal toxicity and microbicidal efficacy.
====================
Excerpted from, "HUMAN VAGINAL-ECTOCERVICAL TISSUE MODEL FOR MICROBICIDE IRRITATION STUDIES" (MatTek Corp. Technical Reference TR-320) - Presented at "Microbicides 2004", London, England, March 28-31, (2004).
====================
Technical References - Microbicide Toxicity, Efficacy Testing
| 431. |
THE RETROCYCLIN ANALOGUE RC-101 PREVENTS HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INFECTION OF A MODEL HUMAN CERVICOVAGINAL TISSUE CONSTRUCT.
|
| 429. |
A HUMAN ORAL TISSUE MODEL TO EVALUATE TOXICITY AND ANTI-HIV ACTIVITY OF THE SPERMICIDE-MICROBICIDE, NONOXYNOL-9M.
|
| 420. |
BIOCOMPATIBILITY OF SOLID DOSAGE ANTI-HIV-1 MICROBICIDES AND VAGINAL PRODUCTS WITH THE MUCOSAL CYTOKINE NETWORK.
|
| 375. |
VAGINAL FORMULATION - HOW INNOCUOUS ARE THEY TO THE VAGINAL EPITHELIAL IMMUME FUNCTION?
|
| 321. |
CONCORDANCE BETWEEN DIFFERENT IN VITRO CULTURE MODELS DESIGNED TO PREDICT VAGINAL IRRITATION AND/OR TOXICITY.
|
| 320. |
HUMAN VAGINAL-ECTOCERVICAL TISSUE MODEL FOR MICROBICIDE IRRITATION STUDIES.
|
| 266. |
ORGANOTYPIC ECTOCERVICO-VAGINAL TISSUE MODEL CONTAINING DENDRITIC CELLS.
|
====================
Request an Electronic Copy (PDF format) of this Technical Paper
====================
EpiVaginal Data Sheet
EpiVaginal Specifications
EpiVaginal Technical References
====================
*Microbicide - any substance that can substantially reduce transmission of sexually transmitted infections (STIs) when applied either in the vagina or the rectum.
|
